Day One and Servier Complete Enrollment in Pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a Front-Line Treatment for Pediatric Low-Grade Glioma (pLGG)

B FIREFLY-2 is the largest study ever conducted in front-line pLGG Trial aims to extend OJEMDA’s indication beyond relapsed/refractory setting to address significant unmet need;…
posteditor
posteditor
Articles: 21727

Other News